Cost of a Peptide Prescription: What You Actually Pay in 2026

The honest answer to "what does a peptide prescription cost?" is: more than people expect on the cheap end, less than the branded sticker price, and almost never what the first ad you click promises. This article breaks down the real 2026 numbers — what you pay for the medication, what you pay for the visit, what you pay for the pharmacy, and where insurance does and does not enter the picture.

The numbers below describe legitimate, physician-prescribed peptide protocols dispensed by licensed 503A compounding pharmacies. They do not describe the gray-market "research peptide" sites that sell unregulated material — those have a separate cost, which is paid in safety rather than dollars.

The four cost components

Every peptide prescription has four pieces. A clinic that quotes a single monthly number has bundled some or all of them; a clinic that breaks them out is being explicit, not necessarily more expensive.

1. The medication itself. The compounded peptide preparation, in the dose and frequency the clinician has set.
2. The telehealth visit fee. The clinician's time for intake and follow-up review. Sometimes bundled into the monthly price, sometimes separate.
3. Pharmacy fulfillment. The compounding pharmacy's preparation, packaging, and dispensing fee, often baked into the medication price.
4. Shipping. Cold-chain or standard shipping from the pharmacy to the patient. Usually $0–$25, sometimes free above a threshold.

When a clinic advertises "$99/month," the question to ask is which of those four are included. A legitimate clinic will tell you without hedging.

GLP-1 microdose: $99–$149 per month

Microdose GLP-1 protocols use a fraction of the standard trial-dose escalation curve — typically a low weekly amount that produces a small appetite signal without the full gastrointestinal response of standard dosing. Because the per-week milligram total is lower, a single compounded vial lasts longer, which is the structural reason microdose protocols cost less.

Real 2026 pricing through legitimate telehealth peptide clinics lands in the $99–$149 per month range for the medication, with most clinics either bundling the visit fee or charging a modest separate follow-up fee. Add roughly $0–$25 for shipping and $0–$99 for the visit if it is broken out separately.

What the patient is paying for: a physician-titrated dose, dispensed by a 503A pharmacy, with regular clinician review. The price floor is set by the actual cost of producing a sterile compounded preparation, not by marketing.

Standard-dose GLP-1: $149–$399 per month

Standard-dose protocols mirror the trial escalation curves more closely — semaglutide-equivalent doses titrating toward 2.4 mg weekly, or tirzepatide-equivalent doses titrating toward 10–15 mg weekly. The medication cost scales with the milligrams dispensed per month, which is why the top of the range can reach $399 at the highest dose tiers.

Mid-range pricing for early-escalation phases sits around $149–$249 monthly. As the dose increases through the protocol, the monthly cost steps up accordingly. A patient who reaches and holds at the top tirzepatide-equivalent dose can expect to pay near the top of the range for as long as that dose continues.

The branded FDA-approved GLP-1 medications priced through traditional pharmacies carry list prices roughly five to ten times higher than compounded equivalents — list prices in the $1,000–$1,500 range per month before any insurance discount. That is a different product category, with different clinical context, but it sets the comparison point most patients arrive with.

NAD+ injectables: $109–$199 per month

NAD+ peptide therapy — typically delivered as subcutaneous self-injection — runs $109–$199 per month for a standard maintenance protocol. The range reflects dose frequency: a once-weekly maintenance dose sits at the lower end, while a more aggressive loading phase or higher-frequency protocol moves toward the top of the range.

NAD+ pricing is relatively stable across legitimate telehealth providers because the underlying compounded preparation is similar between clinics. Where pricing diverges is in the bundle: some clinics include B12/MIC or other adjuncts in the same monthly rate, others price them separately.

Sermorelin and GHRH peptides: $149–$249 per month

Sermorelin, ipamorelin, and other growth-hormone-releasing peptides typically run $149–$249 per month for a standard nightly subcutaneous protocol. Combination preparations — sermorelin paired with a secondary peptide in a single vial — usually price toward the upper half of the range.

GHRH peptide protocols generally use a daily injection cadence rather than the weekly cadence of GLP-1 protocols, which affects how often vials are replaced and therefore the monthly cost. The clinician determines the specific peptide, dose, and combination based on the patient's goals and labs.

The visit fee question

Telehealth peptide visit fees fall into a few buckets in 2026:

• Bundled all-inclusive. The monthly medication price covers initial intake, follow-ups, and ongoing clinician access. Common at clinics that anchor on a monthly rate.
• Visit-separate. Initial intake runs $99–$199, follow-ups are $0–$99, medication is priced separately. Common at clinics that anchor on the medication SKU.
• Membership. A flat monthly or annual access fee covers unlimited visits, with medication priced separately at near-cost. Less common, but emerging.

None of these structures is inherently better. What matters is whether the total — visit plus medication plus shipping — is competitive and whether the clinical contact cadence is real. A "free" follow-up program that never actually schedules a follow-up is worth less than a $50 follow-up fee with a clinician who reviews labs.

Where insurance does and does not fit

Commercial insurance coverage for prescribed peptides follows a clear pattern in 2026:

• FDA-approved branded GLP-1s for documented obesity or type 2 diabetes sometimes get covered after prior authorization. Coverage depends on the plan, the diagnosis, and increasingly on step-therapy requirements. Out-of-pocket cost varies widely.
• Compounded peptide preparations — including most microdose GLP-1 protocols, NAD+, sermorelin, ipamorelin, BPC-157, and similar — are almost never covered. Insurers generally exclude compounded preparations as a category.
• Telehealth visit fees for peptide consultations are sometimes reimbursable as out-of-network telehealth, depending on the plan. Check with your insurer; most peptide clinics will provide a superbill on request.

The realistic posture for a patient considering peptide therapy is to assume cash-pay pricing and treat any insurance reimbursement as a bonus rather than a budgeted offset.

HSA and FSA

Health Savings Accounts and Flexible Spending Accounts are the most common path to use pre-tax dollars for peptide therapy. The general rule: if a licensed clinician has prescribed the peptide for a medical purpose, the medication, visit fee, and shipping are typically eligible.

A few practical points:

• Itemized receipts matter. HSA/FSA administrators will sometimes request documentation showing the medication name, prescriber, and date. Legitimate clinics will provide this without friction.
• Letter of Medical Necessity. Some accounts — particularly FSAs run by stricter administrators — request a Letter of Medical Necessity from the prescriber. A reputable peptide clinic will issue one on request.
• Effective discount. For a patient in a 25% effective marginal tax bracket, paying $150 monthly through an HSA is roughly equivalent to paying $112 in post-tax dollars. Over a year, the difference is meaningful.

What the price floor actually represents

It is worth saying directly: the lower end of the legitimate peptide-pricing range — $99 microdose GLP-1, $109 NAD+, $149 sermorelin — is roughly the floor at which a 503A compounding pharmacy can produce a sterile preparation, a licensed clinician can review and prescribe, and a clinic can deliver the product to the patient with reasonable margin.

Pricing meaningfully below that floor is a signal, not a deal. It usually means one of the four cost components has been cut: the prescription is not from a licensed US clinician, the preparation is not from a 503A pharmacy, the medication is research-grade rather than pharmaceutical-grade, or the operation is offshore and the buyer is the regulatory exposure.

The peptide-therapy industry has a real cost structure. Anything that ignores it is selling something other than what the patient thinks they are buying.

How TelePeptide handles pricing

TelePeptide quotes monthly rates that include the medication, the clinician visit cadence appropriate to the protocol, and standard shipping from the 503A pharmacy partner. The microdose GLP-1 program sits within the $99–$149 range; standard-dose GLP-1 follows the dose-tier curve; NAD+ and GHRH protocols fall within the ranges described above. The clinician determines the protocol; the price tier follows the protocol, not the other way around.

Compounded medications are prepared by licensed 503A pharmacies. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA. Compounded medications are not FDA-approved.